Does Cannabis Have A Possible To Revolutionize Cancer Therapy?

Does Cannabis Have A Possible To Revolutionize Cancer Therapy?

The several advantages of the cannabis plant support the business built around it. And though many research have already revealed what distinguished hashish compounds resembling cannabidiol (CBD) and tetrahydrocannabinol (THC) have to offer, evidently there are still different potential advantages to uncover.

CBD has been commonly generally known as an excellent complement for patients undergoing cancer treatments. According to the American Cancer Society, marijuana helps relieve nausea and vomiting in chemotherapy patients. Citing some studies, the health organization added that people who consume cannabis throughout chemotherapy need painkillers less. It also reiterated that relying solely on the plant for cancer treatment is sick-advised and will lead to severe well being consequences.

What’s very promising, however, is the scientists’ discovery of THC and CBD’s capabilities of slowing the growth or even killing certain types of cancer cells. Just a few organizations seek to totally uncover the cancer-fighting potential of cannabis, and a few researchers may have inched in closer to a groundbreaking discovery.

Cancer-positive mice showcases better survival rates following CBD therapy
Researchers from the Queen Mary University of London and Curtin University, Australia are currently working on a study that dives deep into the cancer-curing potential of CBD.

Citing the research published in Oncogene, Medical Xpress reported that pancreatic cancer-positive mice treated with the compound had better survival rates than these handled solely with an ordinary chemotherapy remedy called Gemcitabine.

Queen Mary University of London’s Prof. Marco Falasca, the examine’s lead researcher, mentioned that the topics treated with best cbd oil survived thrice longer. He added that since the said substance is already accredited to be used in clinics, they can immediately go forward with their research by means of human scientific trials. If profitable, it may be utilized in cancer clinics just as fast.

The company located to catch the rising demand for CBD
This is nice news for cancer sufferers worldwide because it could be the daybreak of better therapy options available for them. The even better news is that the CBD market is already brimming with high-tier brands that deliver high-quality products. Sitting at the high of the chain is PotNetwork Holdings, Inc. (OTCMKTS:POTN).

POTN is provided with an enormous understanding in the analysis and development of CBD products. The extracts it offers to subsidiary Diamond CBD, Inc. is used for the creation of various flavored oils, edibles, capsules, tinctures, vape additives and more.

Nevertheless, POTN and Diamond CBD’s competitive edge shouldn't be the expansive choice of merchandise but their efforts to supply solely CBD extracts of the highest high quality as possible.

The company manually handpicks hemp plants for the extraction process. The chosen plants then undergo supervital CO2 extraction, which isolates the naturally occurring beneficial compound from the hemp. Once the extract has gone through processing, it goes via another high quality check to further ensure that it is pure CBD.

Chi siamo

Ergoproject Plus è una società che si occupa di disabilità e tecnologie, di formazione aziendale finanziata e offre consulenze nell'ambito della sicurezza sul lavoro,
applicando a tutte le sue aree di competenza un approccio ergonomico centrato sull’utente.

Società

Ergoproject Plus Srl
Via Andrea Barbazza 118
00168, Roma
P.IVA – C.F. 14724611000
C.S.I.V. 10.000

info@ergoplus.it

Tel/Fax 06.64467005

Certificazione ISO

BV Certification

Certificazione di qualità ISO 9001:2008,
settori EA di attività 35 e 37

Questo sito fa uso di cookie per migliorare l’esperienza di navigazione degli utenti e per raccogliere informazioni sull’utilizzo del sito stesso. Proseguendo nella navigazione si accetta l’uso dei cookie; in caso contrario è possibile abbandonare il sito.